Suneel Chilukuri, MD, Glynis Ablon, MD
Sponsored by BENEV
Track 3: Industry Hosted Session
Not All Hyaluronic Acid Serums Are Created Equal: Introducing Sente’s next innovation, launching May 22nd
David Goldberg, MD, JD
Sponsored by Sente
Track 3: Industry Hosted Session
A Lasting Treatment for the Patients You See Everyday An IL-23 Inhibitor for Moderate-to Severe Plaque Psoriasis
Naiem Issa, MD
Sponsored by SUN Pharma
Track 3: Industry Hosted Session
New Ingredient to Decrease Melanin: Clinical Results with the latest La Roche-Posay Innovation
Andrew Alexis, MD
Sponsored by La Roche-Posay
Track 3: Industry Hosted Session
Skin Barrier Function in Acne: Implications for Treatments & Skin Care Recommendations
Heather Woolery-Lloyd, MD
Sponsored by CeraVe
Track 3: Industry Hosted Session
Sofwave™ Plus Pure Impact™ Unveiled: Exploring New Indications and Case Studies
Glynis Ablon, MD, Doris Day, MD, Sue Ellen Cox, MD
Sponsored by Sofwave
Track 3: Industry Hosted Session
Diversity in Aesthetic Medicine: Patient Interests & Social Perception
Cheryl Burgess, MD, Steven Dayan, MD, Sabrina Fabi, MD, Terrence Keaney, MD
Sponsored by Allergan Aesthetics, an abbVie company
Track 3: Industry Hosted Session
Turn Your AART into a HIT with the Galderma Portfolio of Aesthetic Injectable Products
Sabrina Fabi, MD
Sponsored by Galderma Laboratories
Track 3: Industry Hosted Session
The First and Only Topical Androgen Receptor Inhibitor
James Q. Del Rosso, DO
Sponsored by SUN Pharma
Track 3: Industry Hosted Session
Bimzelx Has Arrived
Adrian Rodriguez, MD
Sponsored by UCB
Track 3: Industry Hosted Session
